|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depletion, depreciation and accretion (Note 8) | |||||
| Asset impairment (Note 9) | |||||
| Deferred tax (recovery) expense (Note 16) | |||||
| Stock-based compensation expense (Note 13) | |||||
| Amortization of debt issuance costs (Note 11) | |||||
| Non-cash lease expenses | |||||
| Non-cash interest expense | |||||
| Lease payments | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Derivative instruments loss (Note 16) | |||||
| Cash settlement on derivatives instruments (Note 16) | |||||
| Other financial instruments (gain) loss (Note 13) | |||||
| Unrealized derivative instruments (gain) loss (Note 18) | |||||
| Cash settlement of asset retirement obligation (Note 14) | |||||
| Other non-cash (gain) loss | |||||
| Net change in assets and liabilities from operating activities (Note 19) | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Additions to property, plant and equipment (Note 8 and 19) | |||||
| Changes in non-cash investing working capital | |||||
| Cash paid for business combinations, net of cash acquired (Note 3) | |||||
| Proceeds on disposition of property, plant and equipment (Note 8) | |||||
| Cash paid for property acquisitions, net of cash acquired (Note 8) | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of Senior Notes, net of issuance costs | |||||
| Purchase of Senior Notes (Note 11) | |||||
| Senior Notes issuance costs | |||||
| Repayment of Senior Notes (Note 11) | |||||
| Proceeds from debt, net of issuance costs (Note 11) | |||||
| Repayment of debt (Note 11) | |||||
| Lease payments | |||||
| Proceeds from exercise of stock options (Note 13) | |||||
| Re-purchase of shares of Common Stock (Note 13) | |||||
| Net cash (used in) provided by financing activities | |||||
| Foreign exchange gain (loss) on cash and cash equivalents and restricted cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash and cash equivalents, beginning of year (Note 19) | |||||
| Cash and cash equivalents and restricted cash and cash equivalents, end of year (Note 19) | |||||
Loading...